Importantly, YME1L shRNA-induced decrease of GATA3-TIMM44 promoter binding and TIMM44 downregulation were largely attenuated by exogenously adding ATP in P1 glioma cells. This evidence concerns the gene YME1L1 and central nervous system cancer.